SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, effective August 3. The appointment adds public-company financial and capital markets experience as the surgical robotics developer continues its global expansion and advances regulatory initiatives.
Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career. She joins SS Innovations after serving as chief financial officer at Vicarious Surgical, another developer of robotic surgical technologies, where she oversaw financial and operational initiatives designed to reduce cash burn, strengthen the company’s balance sheet and support growth.
The appointment comes at a critical time for SS Innovations, which is pursuing broader commercialization of its SSi Mantra robotic surgical platform while continuing preparations for U.S. Food and Drug Administration review (https://nnw.fm/yY4UM). The company is also expanding internationally, recently graduating the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program. SSICRS welcomed 33 healthcare professionals from seven countries, underscoring the company’s emphasis on surgeon education alongside technology deployment.
Romano’s addition strengthens the company’s financial leadership as it navigates the capital-intensive process of regulatory approval and global market entry. Her experience in raising capital and managing financial operations at a public medtech company will be crucial as SS Innovations seeks to bring its SSi Mantra system to new markets and ultimately achieve FDA clearance in the United States.
The move signals that SS Innovations is preparing for a more aggressive phase of growth, with a seasoned financial executive who understands the challenges of scaling a robotics company in the medtech space. As the company continues to train surgeons internationally and advance its regulatory submissions, the appointment of Romano suggests a focus on financial discipline and strategic capital allocation to support long-term expansion.
For investors, the leadership change underscores SS Innovations’ commitment to building a strong management team capable of executing on its ambitious roadmap. The company’s progress with the SSi Mantra system, combined with its international training initiatives, positions it to compete in the rapidly growing surgical robotics market.
